NJ Invests $1M in Respiratory Device for Lung Patients

Breathing easier just got more accessible for thousands of people living with chronic lung disease.

Synchrony Medical, a respiratory therapy company based in Jersey City, secured a $1 million investment from the New Jersey Innovation Evergreen Fund this week. The company developed LibAirty, an FDA-cleared device that helps patients manage respiratory conditions from the comfort of home.

Founded in 2020, Synchrony Medical focuses on airway clearance therapy for people with chronic lung disease. Their device offers patients an alternative to frequent hospital visits, giving them more control over their daily care.

The state investment came through Edge Medical Ventures, an early-stage investment firm with offices in Jersey City and Israel. It's the first time New Jersey's innovation fund has backed an Israeli-American company, building on a partnership that started in 2018 between the New Jersey Economic Development Authority and Israel Innovation Authority.

"The New Jersey Innovation Evergreen Fund is an excellent model for fostering innovation, playing a key role in establishing our headquarters in New Jersey," said Anat Shai, Synchrony Medical's CEO. The funding will help expand LibAirty's reach across the United States.

The Ripple Effect

This investment does more than help one company grow. New Jersey's Evergreen Fund partners with venture capital firms to support early-stage businesses, creating jobs while strengthening the state's innovation economy.

The model works because it reduces risk for growing companies while keeping talent and innovation rooted in New Jersey. Shai Policker, managing partner at Edge Medical Ventures, points to the state's robust healthcare ecosystem as the perfect foundation for medical innovation to flourish.

For patients managing chronic respiratory conditions, the expansion means greater access to therapy that fits their lives. Home-based care reduces the burden of constant medical appointments while maintaining quality treatment.

New Jersey is proving that smart investments in healthcare technology create wins for everyone: patients get better access to care, companies get room to grow, and communities gain good jobs in a thriving sector.